Cargando…
BG34-200 Immunotherapy of Advanced Melanoma
SIMPLE SUMMARY: Immunotherapy using immune checkpoint inhibitors is now the first line standard of care for advanced melanoma but >50% of patients still do not benefit. Using a recently developed plant-derived glucan molecule called BG34-200, we found that targeting elements of the myeloid compon...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736444/ https://www.ncbi.nlm.nih.gov/pubmed/36497393 http://dx.doi.org/10.3390/cancers14235911 |